In MedTech, innovation rarely waits. Product teams iterate fast, engineering moves aggressively, and commercial teams prepare launches months in advance. Yet one function consistently struggles to keep pace: Regulatory Affairs. This disconnect has quietly become one of the most expensive bottlenecks in the industry. For decades, regulatory teams have been forced to manage growing global …









